OUR CAPITALS
Our Manufactured Capital
OUR CAPITALS
Our Manufactured Capital
It is essential for SANBS to have the necessary resources, including a strong infrastructure and well-defined internal processes and procedures, to guarantee the equitable distribution of blood and blood products to individuals, irrespective of where they are located.
What Manufactured Capital means to SANBS
Our manufactured capital includes our business structures and processes, including physical assets, infrastructure (corporate offices and sites), products and services. Through these, we are able to provide a personalised, safe and efficient experience to advance our purpose of being ‘Trusted to save lives’, ensuring our long-term sustainability.
As an organisation, we are committed to delivering reliable blood products and services, ensuring they are accessible to all patients in a timely manner, of world-class quality, and at reasonable costs. We also strive to meet the increasing expectations and demands of the communities we serve.
To achieve comprehensive coverage, we focus on:
Coverage index
The intent is to ensure coverage on an equitable basis to the entire geographical location that we serve, both urban and rural areas. Additionally, we want to ensure equitable coverage to both the public and private sector:
SANBS Sites
2
testing laboratories (Constantia Kloof and Mount Edgecombe)
83
blood banks and a new one early FY25
72
(FY23: 71) donation centres
7
processing centres
25
mobile donor vehicles (58 beds)
Mount Edgecombe
Mount Edgecombe opened during our FY21. At this location, we introduced the “Journey of Blood” experience, allowing donors and external stakeholders to visit and learn about the blood collection process. Visitors have the opportunity to view the laboratories from designated viewing decks and access detailed information about the procedures through interactive electronic screens.
Successful rollout of BECS marks a substantial leap in our technological capabilities.
Our commitment to innovation is exemplified by the successful rollout of the BECS. This advanced system has revolutionised our blood donation sites, streamlining operations and significantly boosting efficiency. BECS marks a substantial leap in our technological capabilities, enhancing both operational workflows and the overall donor experience.
SANBS has made considerable strides in technological and operational enhancements over the year, notably with the implementation and ongoing optimisation of the BECS. While the BECS rollout marked a significant milestone, it prompted operational adaptations and system refinements for which our team showed exceptional resilience and adaptability. In addition to improving operational efficacy, the BECS implementation prompted an IT infrastructure upgrade, which will facilitate further digitisation opportunities. The successful adoption of BECS, along with a donor app in development, highlights our dedication to innovation and a customer-centric approach, ensuring enhanced workflows and donor experiences as we adapt to the evolving healthcare landscape.
iHEALTh driven simplification of our operations, efficiencies, reducing costs, increasing productivity, and fostering improved collaboration across teams
We continued with many of the iHEALTh strategic projects rendering other notable achievements during the year. These include the significant progress made in streamlining internal procure-to-pay and order-to-billing processes, thus ensuring improved revenue collection and payment of vendors. Successes in collections management have also been significant, with a reduction in debtor days reflecting improved financial stability.
Acknowledgments Received
During this reporting period, SANBS received two prestigious international accreditations, reflecting our unyielding commitment to quality and excellence.
SANBS received the Joint Accreditation Committee ISCT-Europe and EBMT (JACIE) accreditation for our Haematopoetic Stem Cell Transplant (HSCT) programme. This international recognition of SANBS is a testament to the quality of our HSCT service and the commitment of our team to all the patients of South Africa. JACIE accreditation is awarded to HSCT centres that demonstrate ongoing excellence in patient outcomes and stringent commitment to quality standards.
Staff, past and present, are acknowledged for the years of hard work and dedication to achieve this milestone. We look forward to further expanding HSCT services in South Africa. SANBS also received EFI accreditation, a European standard for laboratories engaging in stem cell transplants and transplant testing.